
Gigi Georgiana Huang
Examiner (ID: 703, Phone: (571)272-9073 , Office: P/1621 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1609, 1612, 1629, 1621, 1617, 1613, 1627 |
| Total Applications | 773 |
| Issued Applications | 215 |
| Pending Applications | 86 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5188073
[patent_doc_number] => 20070166381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'OSMOTIC DOSAGE FORM WITH CONTROLLED RELEASE AND FAST RELEASE ASPECTS'
[patent_app_type] => utility
[patent_app_number] => 11/619468
[patent_app_country] => US
[patent_app_date] => 2007-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6448
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166381.pdf
[firstpage_image] =>[orig_patent_app_number] => 11619468
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/619468 | OSMOTIC DOSAGE FORM WITH CONTROLLED RELEASE AND FAST RELEASE ASPECTS | Jan 2, 2007 | Abandoned |
Array
(
[id] => 4751900
[patent_doc_number] => 20080159973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Durable nail coating composition and method of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/646044
[patent_app_country] => US
[patent_app_date] => 2006-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4554
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20080159973.pdf
[firstpage_image] =>[orig_patent_app_number] => 11646044
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/646044 | Durable nail coating composition and method of use thereof | Dec 26, 2006 | Abandoned |
Array
(
[id] => 4772767
[patent_doc_number] => 20080058426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 11/616189
[patent_app_country] => US
[patent_app_date] => 2006-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 864
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11616189
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/616189 | COMPOSITION AND METHOD FOR TREATING PSORIASIS | Dec 25, 2006 | Abandoned |
Array
(
[id] => 5005572
[patent_doc_number] => 20070203144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals'
[patent_app_type] => utility
[patent_app_number] => 11/615876
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4275
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11615876
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/615876 | Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals | Dec 21, 2006 | Abandoned |
Array
(
[id] => 10579808
[patent_doc_number] => 09301919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Sublimable sustained release delivery system and method of making same'
[patent_app_type] => utility
[patent_app_number] => 11/615048
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8263
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11615048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/615048 | Sublimable sustained release delivery system and method of making same | Dec 21, 2006 | Issued |
Array
(
[id] => 5022259
[patent_doc_number] => 20070148225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE'
[patent_app_type] => utility
[patent_app_number] => 11/614910
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4956
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148225.pdf
[firstpage_image] =>[orig_patent_app_number] => 11614910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/614910 | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE | Dec 20, 2006 | Abandoned |
Array
(
[id] => 4866344
[patent_doc_number] => 20080145403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Low temperature processes for making cyclic lipid implants for intraocular use'
[patent_app_type] => utility
[patent_app_number] => 11/612928
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17516
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145403.pdf
[firstpage_image] =>[orig_patent_app_number] => 11612928
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612928 | Low temperature processes for making cyclic lipid implants for intraocular use | Dec 18, 2006 | Issued |
Array
(
[id] => 4866366
[patent_doc_number] => 20080145425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'PHARMACEUTICAL COMPOSITION OF ZOLPIDEM'
[patent_app_type] => utility
[patent_app_number] => 11/611305
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5330
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145425.pdf
[firstpage_image] =>[orig_patent_app_number] => 11611305
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611305 | PHARMACEUTICAL COMPOSITION OF ZOLPIDEM | Dec 14, 2006 | Abandoned |
Array
(
[id] => 4866346
[patent_doc_number] => 20080145405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'DRUG DELIVERY DEVICES'
[patent_app_type] => utility
[patent_app_number] => 11/611674
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7467
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11611674
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611674 | DRUG DELIVERY DEVICES | Dec 14, 2006 | Abandoned |
Array
(
[id] => 5119377
[patent_doc_number] => 20070141091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'BIGUANIDE OINTMENT AND METHOD OF TREATMENT AND PREVENTION OF INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 11/610893
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4037
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141091.pdf
[firstpage_image] =>[orig_patent_app_number] => 11610893
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610893 | BIGUANIDE OINTMENT AND METHOD OF TREATMENT AND PREVENTION OF INFECTIONS | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5119378
[patent_doc_number] => 20070141092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'BIGUANIDE COMPOSITION AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 11/610912
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4244
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141092.pdf
[firstpage_image] =>[orig_patent_app_number] => 11610912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610912 | BIGUANIDE COMPOSITION AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS | Dec 13, 2006 | Abandoned |
Array
(
[id] => 9882651
[patent_doc_number] => 08969415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Intraocular drug delivery systems'
[patent_app_type] => utility
[patent_app_number] => 11/565917
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 23361
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11565917
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565917 | Intraocular drug delivery systems | Nov 30, 2006 | Issued |
Array
(
[id] => 5119434
[patent_doc_number] => 20070141148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Neramexane MR matrix tablet'
[patent_app_type] => utility
[patent_app_number] => 11/604986
[patent_app_country] => US
[patent_app_date] => 2006-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9456
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141148.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604986
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604986 | Neramexane MR matrix tablet | Nov 26, 2006 | Abandoned |
Array
(
[id] => 4758960
[patent_doc_number] => 20080311186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome'
[patent_app_type] => utility
[patent_app_number] => 12/094742
[patent_app_country] => US
[patent_app_date] => 2006-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5475
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311186.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094742
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094742 | Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome | Nov 17, 2006 | Abandoned |
Array
(
[id] => 5236113
[patent_doc_number] => 20070128270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'PHARMACEUTICAL FORMULATIONS CONTAINING 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(2-HYDROXYETHYL)(METHYLSULFONYL)AMINO]-N-METHYL-1-BENZOFURAN-3-CARBOXAMIDE AND METHOD OF MAKING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/558388
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6406
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128270.pdf
[firstpage_image] =>[orig_patent_app_number] => 11558388
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/558388 | PHARMACEUTICAL FORMULATIONS CONTAINING 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(2-HYDROXYETHYL)(METHYLSULFONYL)AMINO]-N-METHYL-1-BENZOFURAN-3-CARBOXAMIDE AND METHOD OF MAKING THE SAME | Nov 8, 2006 | Abandoned |
Array
(
[id] => 4964893
[patent_doc_number] => 20080107713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Contact lens as a sustained drug delivery implant'
[patent_app_type] => utility
[patent_app_number] => 11/594518
[patent_app_country] => US
[patent_app_date] => 2006-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1661
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11594518
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/594518 | Contact lens as a sustained drug delivery implant | Nov 7, 2006 | Abandoned |
Array
(
[id] => 4964915
[patent_doc_number] => 20080107735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Macrocyclic formulations for transmembrane drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/591788
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9588
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107735.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591788 | Macrocyclic formulations for transmembrane drug delivery | Nov 1, 2006 | Abandoned |
Array
(
[id] => 5034133
[patent_doc_number] => 20070098672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Fogger propellant system for containing and dispersing antimicrobial and air freshening compounds'
[patent_app_type] => utility
[patent_app_number] => 11/591814
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1457
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098672.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591814
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591814 | Fogger propellant system for containing and dispersing antimicrobial and air freshening compounds | Nov 1, 2006 | Abandoned |
Array
(
[id] => 5215688
[patent_doc_number] => 20070104769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Bioabsorbable hemostatic gauze'
[patent_app_type] => utility
[patent_app_number] => 11/591154
[patent_app_country] => US
[patent_app_date] => 2006-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7223
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104769.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591154
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591154 | Bioabsorbable hemostatic gauze | Oct 31, 2006 | Abandoned |
Array
(
[id] => 4894004
[patent_doc_number] => 20080103103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Reagents and methods to treat ocular diseases and infection'
[patent_app_type] => utility
[patent_app_number] => 11/590617
[patent_app_country] => US
[patent_app_date] => 2006-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11098
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11590617
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/590617 | Reagents and methods to treat ocular diseases and infection | Oct 29, 2006 | Abandoned |